Clinical Development
| ABL | ||
ABL BV (Analytisch Biologisch Laboratorium) is an independent, global central laboratory dedicated to (multi-centre) clinical trials for pharmaceutical and biotechnological companies. |
ABL-BAS offers a broad range of analytical methods and techniques to support pre-clinical and clinical studies. |
ABL-CTS offers support services for the conduct of multi-site clinical trials ranging from sample logistics and source verification to data and project management. |
SCIEX 4000 Q-Trap LC/MS/MS System, the latest addition to ABL's workforce. This system in concert with the available quantitative radio-active methods for metabolic screening can provide the desired boost for your metabolic research projects. |
ABL-CTS supplies the study sites with all necessary sample shipping materials in compliance with the latest transportation guidelines IATA. Sample-shipments will be arranged in close concert with the participating sites. |
|
| ACE Pharmaceuticals | ||
Our laboratory is a certified, independently operating analytical laboratory, providing advanced and sophisticated analytical services with experienced professionals and state-of-the-art instrumentation. |
Analysis of active ingredients as such, in blends and finished products such as soft and hard gel caps, tablets and capsules. |
Primary packaging - bottling of tablets and capsules. |
ACE's up-to-date premises for the manufacturing of clinical trial medication. |
||
| Baxter Healthcare Corporation's BioPharma Solutions Business | ||
Baxter Healthcare Corporation’s BioPharma Solutions business partners with pharmaceutical companies to enhance their parenteral product offerings. |
PROMAXX microsphere technology offers narrow control of microsphere size and the ability to vary drug release profiles. |
Aseptic processing expertise – Baxter is an industry leader using barrier isolator technology for parenterals. |
We offer high-speed capacity for large-scale syringe filling, aseptic formulation, vial filling and advanced lyophilization. |
Baxter’s portfolio includes a variety of ready-to-administer proprietary systems, such as premix (liquid or frozen) systems, the SOLOMIX admixture system or the CLEARSHOT copolymer prefilled syringe. |
|
| Bibitec | ||
GMP certificated cell culture production site. |
Process development, optimization and production. |
State-of-the-art purification equipment. |
GMP certificated purification suite (cleanrooms class C). |
||
| Binder | ||
The CB Series of CO2 incubator includes the CO2 incubator with hot air sterilisation. |
BINDER is a pioneer in the development and manufacture of simulation chambers for cell cultivation. |
Our products provide the drug development, medical and pharmaceutical industries with the best foundation for success, even after years of operation. |
The pharmaceutical industry uses BINDER simulation chambers to test the shelf life of medicines. |
||
| BIOALVO | ||
HTS platform for drug discovery in a robotic unit. |
CNS drug discovery - human cell line expressing an exogenous human CNS target for secondary HTS. |
CNS drug discovery - human cell line expressing an exogenous human CNS target modelling disease pathobiology. |
BIOALVO - new drug candidates for CNS. |
BIOALVO - revolutionizing the drug discovery arena. |
|
| Cambridge BioScience | ||
All samples have been ethically donated. |
We are able to source normal human tissues from all anatomical sites. |
We offer a complete cardiac safety profiling service that can determine the risk of herg inhibition. |
We offer the world’s most complete ion channel selectivity screening service. |
||
| NascaCell Technologies | ||
Aptamer (colored) binding to a protein (white) by interacting in a small area with phosphate groups (red / orange) and nucleosides protruding into clefts. |
Once selected on a target, aptamers can be used for target validation in cellular assays or in vivo. Since labelled easily, they are also a valuable tool in high throughput screening. |
An aptamer selected on activated Erk2 kinase displays high affinity for the activated enzyme - this aptamer shows significantly less affinity for the non-activated Erk2 kinase. |
Microbodies™ have been modelled into the structure of ß–tryptase (Kiapp of 2nM - 4nM). |
Microbodies™ are extremely stable. Two different Microbodies™ stored in water at different temperatures for 12 weeks showed no significant degradation relative to frozen samples, as observed by HPLC analysis. |
|
